Ciclosporin ophthalmic - AltacorAlternative Names: Cyclosporin A - OphthalmoPharma; Cyclosporin A prodrug - OphthalmoPharma; OPPH 088
Latest Information Update: 10 Aug 2015
At a glance
- Originator CIS Pharma
- Developer Altacor
- Class Antineoplastics; Antipsoriatics; Antirheumatics; Ciclosporins; Eye disorder therapies; Neuroprotectants
- Mechanism of Action Immunosuppressants
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
On Fast track
Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.
- New Molecular Entity No
Highest Development Phases
- Clinical Phase Unknown Dry eyes; Keratoplasty rejection; Uveitis